Matchpoint Therapeutics
Cambridge, MA
Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry libraryevolution. Matchpoint has an emerging pipeline of novel covalent medicines, initially focused on immunology.
http://www.matchpointtx.comCompany Details
Founded
- 2021
Employees
- Between 20 - 50 employees
Raised
- $100,000,000
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
Andre Turenne
Founders
- Tinghu ZhangJianwei CheEdward ChouchaniNathanael Gray
Company Collections
These are collections Matchpoint Therapeutics is a part of. Click on the collection name to view similar companies.
Matchpoint Therapeutics' Industries
Matchpoint Therapeutics Headquarters Location
Total Amount Raised: $100,000,000
Matchpoint Therapeutics Funding Rounds
Series A
$70,000,000
Series A Investors
Sanofi VenturesAlexandria Real Estate EquitiesDigitalis VenturesVertex Ventures HCAccess IndustriesAtlas VentureSeed
$30,000,000
Seed Investors
Access IndustriesAtlas Venture
Matchpoint Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Matchpoint Therapeutics.